Navigation Links
eCardio Announces Publication of Manuscript on The Use of Mobile Cardiac Telemetry to Improve Diagnostic Accuracy and Enable More Efficient Patient Care

HOUSTON, Feb. 28, 2012 /PRNewswire/ -- eCardio Diagnostics (, a leading provider of remote cardiac arrhythmia monitoring, today announced the acceptance for publication of the manuscript titled, "The Use of Mobile Cardiac Telemetry to Improve Diagnostic Accuracy and Enable More Efficient Patient Care." The article appears in the Arrhythmia Section of US Cardiology journal's February issue and is currently available online (

The manuscript's lead author, Steven Zweibel, MD, FACC, FHRS, wrote that even though mobile cardiac telemetry (MCT) is a relatively new technology (first approved by the US Food and Drug Administration in 2002), the use of it has been proven to provide superior diagnostic capability for patients with palpitations, syncope, and pre-syncope because it allows for detection of both symptomatic and asymptomatic arrhythmias, including atrial fibrillation (AFib).

Dr. Zweibel is Director of Electrophysiology at Hartford Hospital and Assistant Professor of Medicine for the University of Connecticut School of Medicine.

The article references a specific patient case study of a 56-year-old male with a history of palpitations with documented runs of both supraventricular tachycardia and AFib. Because the MCT monitor provides specific documentation on the initiation and termination of arrhythmias, Dr. Zweibel received the clinical detail he needed for diagnosing the patient, and he was able to determine that invasive procedures or medication trials would be unnecessary.

"We're thrilled to have such a well-respected electrophysiologist reaffirming the superior clinical benefits of MCT monitors as a cost-effective diagnostic alternative to other available technologies," said Larry Lawson, President and Chief Executive Officer of eCardio Diagnostics. 

"I also believe nationwide insurance carriers will find additional value in documented patient case studies such as Dr. Zweibel's study," said Lawson. "Moving forward, and in the context of total patient healthcare, I hope more insurance carriers will view MCT technology as a cost-conscious way to enable superior member outcomes."

Additionally, Dr. Zweibel stated that the benefits of the MCT monitor were strengthened further through the use of eCardio's uniquely designed Academic Medicine Site (AMS). AMS enables physicians to see data quickly, be alerted to critical and serious heart rhythms, and view reports at any time of day.

According to Paul Minardi, eCardio's Vice President of Academic Medicine, AMS can be configured to the needs of each academic institution or teaching hospital based on their workflow. With AMS, they can track fellowship participation, gain confirmation from attending physicians, regenerate reports and time/date stamp each study with the user's credentials, while allowing for a code of Federal Regulations 21 part 11, HIPAA-compliant electronic signature to be placed on studies.

Minardi said, "We launched eCardio with the belief that physicians needed flexibility, speed and accuracy not only with regards to the devices monitoring their patients, but also from the standpoint of how they would receive information on those patients throughout their studies and maintain that data within their own electronic medical records."

AMS can be provided as a stand-alone tool or customized to work with a variety of EMR systems, and it is continually enhanced as feedback is gained from thousands of end users.

About eCardio
eCardio Diagnostics, LLC (, is one of the nation's leading providers of comprehensive and advanced technologies, devices, services and solutions for the diagnosis, monitoring and subsequent clinical management of cardiac arrhythmias, predominantly in an ambulatory setting.  eCardio provides leading-edge diagnostic innovations and solutions that optimize the flexibility, speed and accuracy of cardiac arrhythmia diagnoses.

About Hartford Hospital
Hartford Hospital, founded in 1854, is one of the largest teaching hospitals and tertiary care centers in New England with one of the region's busiest surgery practices. It is annually ranked among America's Best Hospitals by US News & World Report and has been recognized nationally for the quality of many of its programs, including cardiology, cancer, stroke and joint and spine care. The 867-bed regional referral center provides high-quality care in all clinical disciplines. Among its divisions is The Institute of Living, a 114-bed mental health facility with a national and international reputation of excellence. Jefferson House, a 104-bed long-term care facility, is also a special division of Hartford Hospital. The hospital's major centers of clinical excellence include cardiology, oncology, emergency services and trauma, mental health, women's health, orthopedics, bloodless surgery and advanced organ transplantation. Hartford Hospital owns and operates the state's only air ambulance system, LIFE STAR.

About US Cardiology
US Cardiology ( is a peer-reviewed bi-annual journal comprising review articles, case reports, practice guides, theoretical discussions, and original research. It features balanced and comprehensive articles written by leading authorities, addressing the most important and salient developments in the field of cardiology.

SOURCE eCardio
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Richard Woodyard, Vice President of Sales at eCardio, Loses Fight Against Cancer
2. eCardio Named One of Houstons Fastest Growing Technology Companies at the 2009 Houston Business Journal FastTech 50 Awards Luncheon
3. eCardio Appoints Key Member to Corporate Executive Team
4. eCardio Announces Addition to Senior Leadership Team
5. eCardio Ranked as One of Houstons Fastest Growing Companies
6. AT&T and eCardio Diagnostics Team Up to Advance Cardiac Care Through Innovative Mobile Technology
7. eCardio Diagnostics Announces Three Executive Appointments to Chief Operating Officer, Chief Technology Officer and Executive Vice President
8. eCardio Among Honorees of the Houston Business Journals Fast 100 List for Second Consecutive Year
9. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
10. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
11. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
Post Your Comments:
(Date:11/30/2015)... Diplomat Pharmacy, Inc. (NYSE: DPLO ) ... Free Press as a Top Workplace , among the ... work for in 2015. ... annually, based on employee surveys rating company leadership, career opportunities, ... based solely on employee feedback. The survey is conducted by ...
(Date:11/30/2015)...  IBA Molecular North America, Inc. (IBAMNA), a U.S. ... that as of January 1, 2016, it will do ... to rebrand the company reflects a refined vision for ... close relationship with Zevacor Molecular.  Both IBAMNA and Zevacor ... Peter Burke , Vice President Sales ...
(Date:11/30/2015)... 30, 2015 Baxalta Incorporated (NYSE: ... dedicated to delivering transformative therapies to patients ... today announced the launch and first shipments ... extended circulating half-life recombinant factor VIII (rFVIII) ... ADVATE [Antihemophilic Factor (Recombinant)]. The treatment was ...
Breaking Medicine Technology:
(Date:11/30/2015)... ... November 30, 2015 , ... An ... directory is specialized and only includes chiropractic clinics in the US. , The ... trustworthy alternative health practitioner when back pain sets in. When people are experiencing ...
(Date:11/30/2015)... ... November 30, 2015 , ... In ... Halloween festivities, the Word of Life Christian Church of Flint, MI, hosted a ... a giant 1.25 ton pile of candy dubbed “Candy Mountain”. , A Forever ...
(Date:11/30/2015)... ... November 30, 2015 , ... During ... fundraising campaign to raise funds for its research, education, support, and advocacy efforts. ... organization’s annual funding. , The Mesothelioma Applied Research Foundation, which also goes by ...
(Date:11/30/2015)... ... November 30, 2015 , ... The ... in Dallas, TX, on January 29 and 30, 2016. The course welcomes dental ... of their practices, to learn how to better succeed in the modern dental ...
(Date:11/30/2015)... ... November 30, 2015 , ... HemoTreat™ has announced that the ... ointment to its website. , “Our goal is simple:” says Michael Blasco, HemoTreat’s ... the comparison chart and ingredient list allows our customers to quickly see why, ...
Breaking Medicine News(10 mins):